All News
Secukinumab in Psoriatic Arthritis Patients with Axial Disease
Results of the MAXIMISE trial show that Secukinumab provided clinical improvement and reduction in inflammatory MRI lesions in patients with psoriatic arthritis and axial disease through week 52.
Read Article
How do you treat ACPA+, subclinical synovitis (US/MRI+)? Abst#0481 reviews 3 cohorts for progression to clinical inflam arthritis. 44-68% did not progress to IA in 1 year, is DMARD over treating? #ACR20 #ACRBest @RheumNow
Eric Dein ejdein1 ( View Tweet)
Dr. Phillips touches on a few things to consider how teleheath has changed the delivery of care due to COVID-19. Planning your post-pandemic business strategy, due demand for our specialty, is important. #ACR20 @RheumNow https://t.co/A2dsVy1KSg
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. C Mohan @UTSWNews #ACR20 @rheumnow reviews IFN in SLE:
👉Diff't IFN assc w/diff't lupus manifestions
👉⬆️stim endosomal DNA/RNA sensors RLR7,8,9 may drive SLE
👉TLR7 & 9 in B cells impt for germinal ctrs & Ab prod’n
👉TLR7 is X-linked
👉IFNsig not track w/dz activity https://t.co/3KK3UvH8Ka
k dao KDAO2011 ( View Tweet)
The synovio-entheseal complex theory is proposed in the pathogenesis of psoriatic arthritis. The ultrasound study showed a link in the severity of the sonographic findings in the joints and the entheses supporting this model @rheumnow #ACR20 Abstr#311
Dr. Antoni Chan synovialjoints ( View Tweet)
Sustained remission is rare, should we settle for sustained low disease activity? Abst#0480 ESPOIR Cohort says no, get remission if possible for better radiographic (Sharp) and fxnal (HAQ) scores. Maybe perfect isn't enemy of good? @RheumNow. #ACR20 https://t.co/QNQn9n27rm
Eric Dein ejdein1 ( View Tweet)
Dr Alba reports that in GCA angiotensin II system appears to be activated. Losartan reversed changes and reduced inflammatory markers. Possible role in GCA treatment? @rheumnow #ACR20 Abstr#510 https://t.co/IPp3lD1BUH
Richard Conway RichardPAConway ( View Tweet)
Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain & inflammation ^ chronic pain & other factors ie women high initial pain longer symptoms @CRASCRRheum @RheumNow #ACR20 abstr#187 1/3 at onset have regional pain 1/4 at 1yr https://t.co/7qOxH4h7Dd https://t.co/IFO1uwyR0o
Janet Pope Janetbirdope ( View Tweet)
Dr Ferrada and colleagues assess relapsing polychondritis cohort for VEXAS. Prevalence of 8%. Male sex or age at onset >50 + MCV >100 + platelet count< 200 classified between VEXAS and RP with 100% sens and 96% spec @rheumnow @petercgrayson #ACR20 Abstr#509 #ACRbest https://t.co/5QMu4Y6xSH
Richard Conway RichardPAConway ( View Tweet)
Highlighting results from @rheum_covid at #ACR20
Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al
Abstract #0006👉https://t.co/13jsl8BjcH
Full paper👉https://t.co/Qeo0dOoIOQ
@RheumNow
https://t.co/U9cgaYYaOj
Links:
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow
Bella Mehta bella_mehta ( View Tweet)
#ACR20 Basic Science Year-in-review Really important work by @danaorange showing PRIME cells can predict flares in #RheumatoidArthritis patients #HSSrheum @RheumNow
https://t.co/XTqqinAN2a https://t.co/24HkqgHS0H
Bella Mehta bella_mehta ( View Tweet)
Proud of #HSSRheum! Check out the full list of our 76 Abstracts and 27 moderator and speaker sessions at #ACR20 Convergence here: https://t.co/OoQSzoRxGq. Special congratulations to our two awardees - Roberta Horton and Dr. Jane Salmon! https://t.co/cDkzgFtEH3
HSS Physician-in-Chief HSS_PIC ( View Tweet)
Emerging trend #MachineLearning - SpA expert Dr Dennis Poddubnyy talks at #ACR20 press conference - Development and Validation of an #artificial_intelligence Approach for the Detection of Radiographic Sacroiliitis using MRI @RheumNow
Bella Mehta bella_mehta ( View Tweet)
#ACR20 year in review by @JYazdanyMD latest data PEXIVAS and SEMIRA trials on corticosteroids - would you change your clinical practice to minimize even low dose Corticosteroids in RA and Vasculitis? @RheumNow
https://t.co/l7PTyANpjq
https://t.co/MRGbsjaGae
Bella Mehta bella_mehta ( View Tweet)
Ready for #ACR20 with an obstructed view. @RheumNow https://t.co/oFVc90DpEM
Eric Dein ejdein1 ( View Tweet)
ACR president Dr. Ellen Gravallese: "We should be in the room where it happens" because "our knowledge and insights are highly relevant" #ACR20 @RheumNow #Hamilton
Eric Dein ejdein1 ( View Tweet)
"Educational conferences will never be the same" Ellen Gravallese, MD. Already in action at #ACR20 @RheumNow
Eric Dein ejdein1 ( View Tweet)
Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.
Eric Dein ejdein1 ( View Tweet)
Eric Rubin, MD, editor-in-chief @NEJM: "All of the vaccines are based on the same hypothesis". Scary thought in relying in one solution #ACR20. @RheumNow
Eric Dein ejdein1 ( View Tweet)